Navigation Links
Reportlinker Adds Global Immunochemicals Industry
Date:6/14/2011

NEW YORK, June 14, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Immunochemicals Industry

http://www.reportlinker.com/p0552748/Global-Immunochemicals-Industry.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharma

This report analyzes the worldwide markets for Immunochemicals in US$ million by the following product segments – Catalog Antibodies, and Custom Antibodies. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, China, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 129 companies including many key and niche players such as Abbott Diagnostics, Advanced ImmunoChemical, Beckman Coulter, Inc., BioCat GmbH, BIOTREND Chemikalien GmbH, Bio-Rad Laboratories, Inc., Dako, Life Technologies Corporation, Maine Biotechnology Services, Meridian Life Science®, Inc., Millipore Corporation, MitoSciences, Inc., MorphoSys AG, Randox Laboratories Ltd., Roche Group, Rockland Immunochemicals, Sigma-Aldrich Co., and Trinity Biotech, PLC. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Data Interpretation & Reporting Level 3

Quantitative Techniques & Analytics 3

Product Definitions and Scope of Study 3

Catalog Antibodies 4

Custom Antibodies 4

2. INDUSTRY OVERVIEW 5

Escalating Demand for Immunochemicals 5

Antibodies: Critical Role in Drug Discovery and Research 5

Animal-Based Technologies Lose Ground to Alternative Approaches 6

Current and Future Analysis 6

Emerging Markets Offer Huge Potential 7

Custom Antibodies: Finding Favor in Research Applications 7

Research Antibodies- Linked to Prospects of Therapeutic

Antibody Market 7

Antibody Manufacturers Face Threat from Academics Sector 8

Table 1: Global Immunochemicals Market (2010E): Percentage

Share Breakdown of Revenues by Sector for Academic and

Pharmaceutical & Biotech 8

Competitive Scenario 8

Factors Affecting Competitiveness of Players in the Global

Immunochemicals Market - Ranked by Importance for Purchasers 9

3. AN INTRODUCTION TO IMMUNOCHEMICALS 10

Immunochemicals 10

Types of Immunochemicals 10

Catalog Antibodies 10

Custom Antibodies 10

Applications of Immunochemicals 11

Healthcare 11

Environmental Science 11

Crop Protection and Biotechnology 11

Leading Research Areas 11

Table 2: Leading Research Areas in the Global Immunochemicals

Market (2010E): Percentage Share Breakdown for Immunology,

Neurobiology, Signal Transduction, Developmental Biology,

Cardiovascular, Virology, and Others (includes corresponding

Graph/Chart) 12

Common Techniques Used for Research in the Global

Immunochemicals Market 12

4. ANTIBODIES - A PRIMER 13

Introduction to Antibodies 13

Primary and Secondary Antibodies 13

Antibodies in Research Applications 14

Table 3: Antibody Usage in Research Sector (2009): Percentage

Share Breakdown of Revenues by Platform for Flow Cytometry,

ELISA, Protein Arrays, and Others (includes corresponding

Graph/Chart) 15

Monoclonal Antibodies 15

Properties 15

Applications 16

Polyclonal Antibodies 16

Production Process 16

Properties 17

Applications 17

Conjugate Antibodies 17

5. MONOCLONAL ANTIBODY MARKET - AN OVERVIEW 18

Introduction 18

Asia: A Lucrative Market 18

China - The Fastest Growing mAb Market 18

Significant Growth in Therapeutic and Diagnostic Applications 19

Shift Towards Humanized and Fully Human Antibodies 19

Advancements & Challenges in Antibody Production Processes 20

Future of mAbs - Smaller and Inexpensive to Produce 20

Structurally Modified Full-Size mAbs - Next Type of mAbs to

Hit the Market 20

MAb Fragments 21

Competitive Scenario 21

6. PRODUCT INTRODUCTIONS/INNOVATIONS 23

AMSBIO Introduces Rabbit Monoclonal and Polyclonal Antibodies

Portfolio 23

Immunocore Initiates Clinical Trials for IMCgp100 23

bioMérieux Introduces VIDAS® EBV 24

PerkinElmer Introduces LANCE® Ultra Assay Products 24

Radiometer Introduces NT-proBNP in AQT90 FLEX Immunoassay

Analyzer Test Menu 25

Radiometer Introduces C-Reactive Protein in AQT90 FLEX

Immunoassay Analyzer 25

Diagnostic Biosystems Introduces IVD Labeled Staining Reagents

Range 25

Radiometer Adds bhCG Pregnancy Marker to AQT90 FLEX

Immunoassay Analyzer 25

Qualigen Introduces FastPack® hCG Immunoassay 26

Enterix Launches InSure® Quik F I T™ Fecal Immunochemical Test 26

Amgen Introduces Vectibix 26

Trevigen Introduces Mouse Monoclonal Antibody 26

7. RECENT INDUSTRY ACTIVITY 27

Rockland Immunochemicals Receives Grants from NIH 27

Bio-Rad Laboratories Acquires Diagnostic Businesses from Biotest 27

Beckman Coulter Takes Over Diagnostic Business of Olympus 27

Roche Takes Over Genentech 28

GED Capital to Acquire Majority Stake in Diamedix 28

PerkinElmer Enters into Collaboration with BioLegend 28

Abbott Inks Agreement with BG Medicine 29

Ortho Clinical Diagnostics Receives FDA Approval for VITROS®

HBsAg Assay 29

Athera Inks Agreements with Oxford Biosystems and Asbach

Medical Products 30

CTI Acquires AVANT Immunotherapeutics 30

Clinical Genomics Enters into Global License Agreement with

Quest Diagnostics 30

Sigma-Aldrich Obtains Seppro Affinity Depletion Technology

from GenWay Biotech 31

Siemens to Merge with Siemens Healthcare Diagnostics 32

Merck Acquires Bangalore Genei 32

Commonwealth Biotechnologies to Purchase GL Biochem 32

Intercell Takes Over Iomai 32

Thermo Fisher Scientific Takes Over Open Biosystems 33

Thermo Fisher Scientific Acquires Affinity BioReagents 33

Daiichi Sankyo Takes Over U3 Pharma 33

IMUC Completes Molecular Antibody Technology Acquisition 34

EUSA Pharma to Take Over Cytogen 34

Access Pharmaceuticals Acquires Somanta Pharmaceuticals 35

Genmab Enters into Antibody Research Collaboration with Pepscan 35

BTI Enters into an Agreement with Raven 35

Eusa Sells Antibody Research Business 35

AVANIR Inks Definitive Agreement to Divest Anthrax Antibodies 36

CG Therapeutics and UoW Agree for Joint Monoclonal Antibody

Program 36

SDI to Develop mAbs for SAIC-F and NCI 36

Morphotek and HMI in Licensing Agreement 37

Amgen Enters into Licensing Agreement with Kyowa Hakko 37

Dyax and Sanofi-Aventis Sign Agreements 38

HGS Enters into Antibody Collaboration Agreement with Xencor 38

Biogen Partners with Genentech and Roche for Development of

GA-101 39

Tecan Commences Operations at Refurbished Facility 39

8. FOCUS ON SELECT PLAYERS 40

Abbott Diagnostics (UK) 40

Advanced ImmunoChemical (US) 40

Beckman Coulter, Inc. (US) 40

BioCat GmbH (Germany) 41

BIOTREND Chemikalien GmbH (Germany) 41

Bio-Rad Laboratories, Inc. (US) 42

Dako (Denmark) 42

Life Technologies Corporation (US) 42

Maine Biotechnology Services (US) 43

Meridian Life Science®, Inc. (US) 43

Millipore Corporation (US) 43

MitoSciences, Inc. (US) 44

MorphoSys AG (Germany) 44

Randox Laboratories Ltd. (UK) 45

Roche Group (Switzerland) 45

Rockland Immunochemicals (US) 46

Sigma-Aldrich Co (US) 47

Trinity Biotech, PLC (Ireland) 47

9. GLOBAL MARKET PERSPECTIVE 48

Table 4: World Recent Past, Current & Future Analysis for

Immunochemicals by Geographic Region - US, Canada, Japan,

Europe, China and Rest of World Markets Independently Analyzed

with Annual Revenue Figures in US$ Million for Years 2009

through 2017 (includes corresponding Graph/Chart) 48

Table 5: World Historic Review for Immunochemicals by

Geographic Region - US, Canada, Japan, Europe, China and Rest

of World Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2003 through 2008 (includes

corresponding Graph/Chart) 49

Table 6: World 15-Year Perspective for Immunochemicals by

Geographic Region - Percentage Breakdown of Annual Revenues

for US, Canada, Japan, Europe, China and Rest of World Markets

for Years 2003, 2010 & 2017 (includes corresponding

Graph/Chart) 50

Table 7: World Recent Past, Current & Future Analysis for

Catalog Antibodies by Geographic Region - US, Canada, Japan,

Europe, China and Rest of World Markets Independently Analyzed

with Annual Revenue Figures in US$ Million for Years 2009

through 2017 (includes corresponding Graph/Chart) 51

Table 8: World Historic Review for Catalog Antibodies by

Geographic Region - US, Canada, Japan, Europe, China and Rest

of World Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2003 through 2008 (includes

corresponding Graph/Chart) 52

Table 9: World 15-Year Perspective for Catalog Antibodies by

Geographic Region - Percentage Breakdown of Annual Revenues

for US, Canada, Japan, Europe, China and Rest of World Markets

for Years 2003, 2010 & 2017 (includes corresponding

Graph/Chart) 53

Table 10: World Recent Past, Current & Future Analysis for

Custom Antibodies by Geographic Region - US, Canada, Japan,

Europe, China and Rest of World Markets Independently Analyzed

with Annual Revenue Figures in US$ Million for Years 2009

through 2017 (includes corresponding Graph/Chart) 54

Table 11: World Historic Review for Custom Antibodies by

Geographic Region - US, Canada, Japan, Europe, China and Rest

of World Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2003 through 2008 (includes

corresponding Graph/Chart) 55

Table 12: World 15-Year Perspective for Custom Antibodies by

Geographic Region - Percentage Breakdown of Annual Revenues

for US, Canada, Japan, Europe, China and Rest of World Markets

for Years 2003, 2010 & 2017 (includes corresponding

Graph/Chart) 56

10. THE UNITED STATES 57

Market Analysis 57

Table 13: US Recent Past, Current & Future Analysis for

Immunochemicals by Type - Catalog Antibodies and Custom

Antibodies Markets Independently Analyzed with Annual

Revenue Figures in US$ Million for Years 2009 through 2017

(includes corresponding Graph/Chart) 57

Table 14: US Historic Review for Immunochemicals by Type -

Catalog Antibodies and Custom Antibodies Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) 58

Table 15: US 15-Year Perspective for Immunochemicals by Type -

Percentage Breakdown of Annual Revenues for Catalog

Antibodies and Custom Antibodies Markets for Years 2003,

2010 & 2017 58

11. CANADA 59

Market Analysis 59

Table 16: Canadian Recent Past, Current & Future Analysis

for Immunochemicals by Type - Catalog Antibodies and Custom

Antibodies Markets Independently Analyzed with Annual

Revenue Figures in US$ Million for Years 2009 through 2017

(includes corresponding Graph/Chart) 59

Table 17: Canadian Historic Review for Immunochemicals by

Type - Catalog Antibodies and Custom Antibodies Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) 60

Table 18: Canadian 15-Year Perspective for Immunochemicals

by Type - Percentage Breakdown of Annual Revenues for

Catalog Antibodies and Custom Antibodies Markets for Years

2003, 2010 & 2017 60

12. JAPAN 61

Market Analysis 61

Table 19: Japanese Recent Past, Current & Future Analysis

for Immunochemicals by Type - Catalog Antibodies and Custom

Antibodies Markets Independently Analyzed with Annual

Revenue Figures in US$ Million for Years 2009 through 2017

(includes corresponding Graph/Chart) 61

Table 20: Japanese Historic Review for Immunochemicals by

Type - Catalog Antibodies and Custom Antibodies Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) 62

Table 21: Japanese 15-Year Perspective for Immunochemicals

by Type - Percentage Breakdown of Annual Revenues for

Catalog Antibodies and Custom Antibodies Markets for Years

2003, 2010 & 2017 62

13. EUROPE 63

Market Analysis 63

Table 22: European Recent Past, Current & Future Analysis

for Immunochemicals by Type - Catalog Antibodies and Custom

Antibodies Markets Independently Analyzed with Annual

Revenue Figures in US$ Million for Years 2009 through 2017

(includes corresponding Graph/Chart) 63

Table 23: European Historic Review for Immunochemicals by

Type - Catalog Antibodies and Custom Antibodies Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) 64

Table 24: European 15-Year Perspective for Immunochemicals

by Type - Percentage Breakdown of Annual Revenues for

Catalog Antibodies and Custom Antibodies Markets for Years

2003, 2010 & 2017 64

14. CHINA 65

A.Market Analysis 65

Outlook 65

A Rapidly Expanding mAb Market 65

Strengths and Opportunities 65

Target-Specific Nature of Monoclonal Antibodies 65

Rising Incidence of Cancer & Age-Related Conditions:

Potential Opportunity 65

Manufacturing Advancements 66

Less Serious Side-Effects 66

Deep Pipeline 66

High Cost of mAb Treatment in the EU and US 66

Challenges Facing mAb Market 67

High Manufacturing and Development Cost 67

Mode of Administration 67

Strong Competition 67

Expiration of Patents 67

Immunogenicity 68

Regulatory Concerns 68

Financial Limitation 68

Low Reimbursement for mAb 68

B.Market Analytics 69

Table 25: Chinese Recent Past, Current & Future Analysis for

Immunochemicals by Type - Catalog Antibodies and Custom

Antibodies Markets Independently Analyzed with Annual

Revenue Figures in US$ Million for Years 2009 through 2017

(includes corresponding Graph/Chart) 69

Table 26: Chinese Historic Review for Immunochemicals by

Type - Catalog Antibodies and Custom Antibodies Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) 70

Table 27: Chinese 15-Year Perspective for Immunochemicals by

Type - Percentage Breakdown of Annual Revenues for Catalog

Antibodies and Custom Antibodies Markets for Years 2003,

2010 & 2017 70

15. REST OF WORLD 71

A.Market Analysis 71

Outlook 71

Asia Offers Enormous Opportunities for mAb Market 71

B.Market Analytics 72

Table 28: Rest of World Recent Past, Current & Future

Analysis for Immunochemicals by Type - Catalog Antibodies

and Custom Antibodies Markets Independently Analyzed with

Annual Revenue Figures in US$ Million for Years 2009 through

2017 (includes corresponding Graph/Chart) 72

Table 29: Rest of World Historic Review for Immunochemicals

by Type - Catalog Antibodies and Custom Antibodies Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) 73

Table 30: Rest of World 15-Year Perspective for

Immunochemicals by Type - Percentage Breakdown of Annual

Revenues for Catalog Antibodies and Custom Antibodies

Markets for Years 2003, 2010 & 2017 73

COMPETITIVE LANDSCAPE

Total Companies Profiled: 129 (including Divisions/Subsidiaries - 136)

------------------------------------------

Region/Country Players

------------------------------------------

The United States 83

Canada 3

Japan 3

Europe 41

France 7

Germany 7

The United Kingdom 9

Rest of Europe 18

Asia-Pacific (Excluding Japan) 6

------------------------------------------

To order this report:

Biopharmaceutical Industry: Global Immunochemicals Industry

Biopharmaceutical Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related biology technology :

1. Reportlinker Adds Industrial Biotechnology China News 1105 - Annual Subscription
2. Reportlinker Adds Future of White Biotechnology in China
3. Reportlinker Adds Whats Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 2011-2015
4. Reportlinker Adds Orthopedic Biomaterials, The World Market
5. Reportlinker Adds Biochips and Microarrays - Technologies, markets and companies
6. Reportlinker Adds Osteosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2017
7. Reportlinker Adds Future Directions in Regenerative Medicine
8. Reportlinker Adds Innovations in Protein Kinase Therapies - Significant Proportion of Protein Kinase Pipeline Contains Small Molecule Drugs That Target Oncology
9. Reportlinker Adds Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries
10. Reportlinker Adds Analytical Tool - Lymphoma
11. Reportlinker Adds Enzymes: Sustainable Alternatives with Remarkable Scope
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... OXFORD, England , December 8, 2016 ... Company, has expanded its customisable SureSeqâ„¢ NGS panel range with ... - allowing fast and cost-effective study of variants in familial ... copy number variation (CNV) detection on a single small panel ... and hotspot content. This includes all exons for LDLR ...
(Date:12/8/2016)... CA (PRWEB) , ... December 08, 2016 , ... ... as finalists in the World Technology Awards. uBiome is one of just six ... across all categories. , In addition to uBiome, companies nominated as finalists in ...
(Date:12/8/2016)... Dec. 8, 2016  HedgePath Pharmaceuticals, Inc. (OTCQX: ... develops and plans to commercialize innovative therapeutics for ... common stock were approved for trading on the ... on the OTCQX, effective today, under the ticker ... OTCQX market, companies must meet high financial standards, ...
(Date:12/8/2016)... 8, 2016   Biocept, Inc . (NASDAQ: ... of clinically actionable liquid biopsy tests to improve ... data featuring its Target Selectorâ„¢ Circulating Tumor Cell ... the detection of actionable biomarkers in patients with ... by Sara Cannon Research Institute (SCRI), the research ...
Breaking Biology Technology:
(Date:11/15/2016)... 15, 2016 Research and Markets has announced ... 2021" report to their offering. ... ... by 2021 from USD 6.21 Billion in 2016, growing at a ... of the bioinformatics market is driven by the growing demand for ...
(Date:6/27/2016)... , June 27, 2016 Research and ... North America 2016-2020" report to their offering. ... North America to grow at a CAGR of ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
(Date:6/22/2016)... On Monday, the Department of Homeland Security (DHS) issued ... the Biometric Exit Program. The Request for Information (RFI), ... that CBP intends to add biometrics to confirm when ... , in order to deter visa overstays, to ... Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
Breaking Biology News(10 mins):